Molecular mechanism of enhanced apoptotic response in U937 cells mediated by sodium butyrate.
- Author:
Jianfeng ZHOU
1
;
Yi TANG
;
Wenli LIU
;
Hanying SUN
;
Junbo HU
;
Jianping GONG
Author Information
- Publication Type:Journal Article
- MeSH: Apoptosis; Butyrates; pharmacology; Carrier Proteins; metabolism; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; metabolism; Proto-Oncogene Proteins c-bcl-2; metabolism; U937 Cells; bcl-Associated Death Protein; p38 Mitogen-Activated Protein Kinases
- From: Chinese Journal of Oncology 2002;24(4):320-322
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the effects of sodium butyrate (NaBu) on cell cycle checkpoint and the apoptosis sensitivity in U937 cells.
METHODSTwo mutant U937 cell lines, U937-ASPI3K (ATM negative) and U937-pZeosv2(+) (ATM wild-type), were used as the cell model system. Immunoprecipitation and kinase assay were used to examine the p38 MAPK and ERK1 kinase activities. Western blot was used to analyze the phosphorylation of Bad protein.
RESULTSU937-pZeosv2(+) pretreated with NaBu exhibited enhanced apoptotic response in a NaBu dose dependent fashion upon (137)Cs irradiation, which could be abolished by olomoucine (OLM), a p38 MAPK specific inhibitor. On the other hand, Cyclin dependent kinase 2 (CDK2) specific inhibitor CDK2-I and p34cdc2/cyclinB inhibitor alsterpaullone (ALP) failed to block the effects of NaBu. Similar results were also observed in U937-ASPI3K. The effect of irradiation on p38 MAPK and ERK1 was strikingly potentiated by NaBu. Furthermore, inactivation of irradiated Bad protein via phosphorylation on serine 136 was also enhanced.
CONCLUSIONNaBu is able to enhance the apoptotic response in U937 cells, which is mediated by p38 MAPK activation but not ATM status.
